Cecilia Anna Wilhelmina Geuijen

Cecilia Anna Wilhelmina Geuijen

Chief Tech/Sci/R&D Officer bei MERUS N.V.

56 Jahre
Consumer Services
Health Technology

Ursprung des Netzwerks ersten Grades von Cecilia Anna Wilhelmina Geuijen

EinheitArt der EinheitIndustrie
Public Company Biotechnology 19

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Cecilia Anna Wilhelmina Geuijen

UnternehmenSektorVerknüpfte PersonenHauptposition
Pharmaceuticals: Major

Bill Lundberg

Chief Tech/Sci/R&D Officer

Biotechnology

Len Kanavy

Corporate Officer/Principal

ALEXION PHARMACEUTICALS, INC. Pharmaceuticals: Major

Bill Lundberg

Corporate Officer/Principal

Medical Specialties

Bill Lundberg

Chief Tech/Sci/R&D Officer

Pharmaceuticals: Major

Mark Iwicki

Director/Board Member

Antisoma Research Ltd.

Bill Lundberg

Corporate Officer/Principal

Pharmaceuticals: Major

Mark Iwicki

Director/Board Member

KALA BIO, INC. Pharmaceuticals: Major

Gregory Perry

Mark Iwicki

Director/Board Member

Chief Executive Officer

Biotechnology

Mark Iwicki

Director/Board Member

ACLARIS THERAPEUTICS, INC. Pharmaceuticals: Major

Maxine Gowen

Anand Mehra

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Mark Iwicki

Director/Board Member

Investment Managers

Mark Iwicki

Consultant / Advisor

Massachusetts Institute of Technology College/University

Bill Lundberg

Andrew Joe

Undergraduate Degree

Undergraduate Degree

College/University

Sherri L. Spear

Undergraduate Degree

Ithaca College College/University

Shannon Campbell

Undergraduate Degree

Loyola University Maryland, Inc. College/University

Mark Iwicki

Masters Business Admin

University of Scranton College/University

Len Kanavy

Masters Business Admin

Pharmaceuticals: Major

Mark Iwicki

Corporate Officer/Principal

University of Utrecht College/University

John de Kruif

Doctorate Degree

Icahn School of Medicine at Mount Sinai College/University

Andrew Joe

Graduate Degree

Investment Banks/Brokers

Sherri L. Spear

Analyst-Equity

Biotechnology

Mark Iwicki

Chief Executive Officer

Stanford University School of Medicine College/University

Bill Lundberg

Doctorate Degree

AIMMUNE THERAPEUTICS, INC. Pharmaceuticals: Major

Mark Iwicki

Director/Board Member

CRISPR THERAPEUTICS AG Biotechnology

Bill Lundberg

Chief Tech/Sci/R&D Officer

Philadelphia College of Pharmacy College/University

Ashley Pereira

Graduate Degree

PULMATRIX, INC. Pharmaceuticals: Major

Mark Iwicki

Chairman

Pharmaceuticals: Major

Mark Iwicki

Director/Board Member

BLACK DIAMOND THERAPEUTICS, INC. Biotechnology

Shannon Campbell

Director/Board Member

VOR BIOPHARMA INC. Biotechnology

Bill Lundberg

Director/Board Member

Pharmaceuticals: Major

Len Kanavy

Corporate Officer/Principal

Biotechnology

Mark Iwicki

Bill Lundberg

Chairman

Director/Board Member

THIRD HARMONIC BIO, INC.

Mark Iwicki

Chairman

AEROVATE THERAPEUTICS, INC.

Mark Iwicki

Director/Board Member

AKERO THERAPEUTICS, INC. Pharmaceuticals: Major

Mark Iwicki

Chairman

RALLYBIO CORPORATION Biotechnology

Liu Hui

Director/Board Member

Genentech Access To Care Foundation

Len Kanavy

Director/Board Member

Statistik

International

Vereinigte Staaten 38
Niederlande 4
Vereinigtes Königreich 4
Schweiz 2

Sektoral

Health Technology 26
Consumer Services 9
Finance 8
Commercial Services 3

Operativ

Director/Board Member 70
Corporate Officer/Principal 36
Independent Dir/Board Member 36
Director of Finance/CFO 12
Undergraduate Degree 12